MedTrace Logo

Empowering Patients on Choices for Renal Replacement Therapy (Aim 2)

NCT02440659 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2946

Last updated 2017-05-10

Study results available
· View outcomes & findings →

Summary

Empowering Patients On Choices for Renal Replacement Therapy (EPOCH-RRT) study seeks to identify factors that matter the most to patients with kidney disease and study how they are impacted by different types of dialysis. The inclusion of patients, caregivers, and patient advocacy organizations as research partners will assure that the study addresses questions of greatest relevance to patients facing the need for dialysis.

Aim two is based on preliminary results of Aim one interviews, and in collaboration with the Patient Advisory Panel, the investigators developed a brief questionnaire to be administered to participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS) and Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Two separate versions of the questionnaire were created to reflect unique aspects of in-center hemodialysis (HD) and peritoneal dialysis (PD).

Conditions

Sponsors & Collaborators

  • University of Michigan

    collaborator OTHER

  • Henry Ford Health System

    collaborator OTHER

  • National Kidney Foundation, United States

    collaborator OTHER

  • American Association of Kidney Patients

    collaborator OTHER

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Arbor Research Collaborative for Health

    lead OTHER

Principal Investigators

  • Francesca Tentori, MD, MS · Arbor Research Collaborative for Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-08-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02440659 on ClinicalTrials.gov